US FDA generics chief moves to new role
08 March 2010
Vibha Sharma
Gary Buehler, who has been the head of the US
Food and Drug Administration’s Office of Generic Drugs for nearly a decade, is moving to a new role within the agency. In his new position, Mr Buehler will play a key role in negotiations and activities relating to generic drug user fees.
Mr Buehler...
Please Login to read the full article.
08 March 2010
Vibha Sharma
Mr Buehler...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- Generic industry, FDA agree on $299M for US user fee programme
- BIO's policy agenda, UK's Blair featured highlights at 2011 biotech conference
- FDA's Woodcock attributes 35 NME approvals to agency flexibility, creativity
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
